Scotiabank cut shares of CRH Medical Corp (NYSEARCA:CRHM) from an outperform rating to a sector perform rating in a research report sent to investors on Friday morning.

Other research analysts have also issued research reports about the company. Zacks Investment Research upgraded CRH Medical Corp from a sell rating to a hold rating in a research report on Tuesday, May 2nd. Cantor Fitzgerald reiterated an overweight rating and issued a $10.00 target price (up previously from $8.00) on shares of CRH Medical Corp in a research report on Monday, March 27th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $8.88.

CRH Medical Corp (NYSEARCA:CRHM) traded down 1.32% during mid-day trading on Friday, hitting $3.75. 497,350 shares of the company were exchanged. The firm has a 50 day moving average price of $5.77 and a 200 day moving average price of $6.56. CRH Medical Corp has a 12 month low of $3.44 and a 12 month high of $9.25.

ILLEGAL ACTIVITY NOTICE: “CRH Medical Corp (CRHM) Downgraded to Sector Perform at Scotiabank” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/07/17/crh-medical-corp-crhm-downgraded-to-sector-perform-at-scotiabank.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. ARP Americas LLC raised its position in CRH Medical Corp by 7.4% in the first quarter. ARP Americas LLC now owns 13,042 shares of the company’s stock worth $107,000 after buying an additional 900 shares in the last quarter. Tower Research Capital LLC TRC raised its position in CRH Medical Corp by 15,344.4% in the first quarter. Tower Research Capital LLC TRC now owns 13,900 shares of the company’s stock worth $114,000 after buying an additional 13,810 shares in the last quarter. Acadian Asset Management LLC bought a new position in CRH Medical Corp during the first quarter worth about $150,000. KCG Holdings Inc. raised its position in CRH Medical Corp by 40.1% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company’s stock worth $160,000 after buying an additional 5,579 shares in the last quarter. Finally, Bank of Montreal Can raised its position in CRH Medical Corp by 128.4% in the second quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock worth $164,000 after buying an additional 16,135 shares in the last quarter.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.